Ignite Creation Date:
2025-12-25 @ 1:06 AM
Ignite Modification Date:
2026-03-12 @ 1:05 AM
Study NCT ID:
NCT05550493
Status:
COMPLETED
Last Update Posted:
2022-12-02
First Post:
2022-09-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Digital Therapeutics Smartphone Application for Methamphetamine Use Disorder
Sponsor:
Adai Technology (Beijing) Co., Ltd.
Organization:
Study Overview
Official Title:
Preliminary Efficacy of a Digital Therapeutics Smartphone Application for Methamphetamine Use Disorder
Status:
COMPLETED
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
One hundred participants were recruited and randomized into a digital therapeutics (DTx) group (n=52) and a treatment as usual (TAU) group (n=48). The DTx group used a smartphone application to deliver cognitive behavioral therapy, approach bias modification, cognitive training, and contingency management for eight weeks. The TAU group received counseling from social workers and psychoterapists. Cue-induced craving, cognitive functions, PHQ-9, and GAD-7 were measured at baseline and post-intervention.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: